Not applicableNot Yet RecruitingNCT06286215What this trial is testingRegistry of Patients With Plasma Cell DisordersWho this might be right forPlasma Cell Disorders Siriraj Hospital 750
Large-scale testing (Phase 3)Active Not RecruitingNCT03480360What this trial is testingHaploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' ExpressionWho this might be right forAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more Dartmouth-Hitchcock Medical Center 21
Early research (Phase 1)Study completedNCT00952237What this trial is testingImmune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSFWho this might be right forNon-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma+2 more Dartmouth-Hitchcock Medical Center 13
Not applicableNot Yet RecruitingNCT06330896What this trial is testingDisease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation SequencingWho this might be right forPlasma Cell Disorder Siriraj Hospital 498
Not applicableUnknownNCT03405571What this trial is testingValidation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.Who this might be right forMultiple MyelomaVenous Thromboembolism University of Athens 800
Testing effectiveness (Phase 2)Looking for participantsNCT04879043What this trial is testingStudy to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple MyelomaWho this might be right forMultiple MyelomaPlasma Cell Disorder Heidelberg Pharma AG 78
Testing effectiveness (Phase 2)Study completedNCT02632786What this trial is testingThe PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) AmyloidosisWho this might be right forAL Amyloidosis Prothena Biosciences Ltd. 129
Very early researchNot Yet RecruitingNCT07365059What this trial is testingSafety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell DisordersWho this might be right forPlasma Cell Dyscrasias Qi deng 18
Not applicableLooking for participantsNCT03616483What this trial is testingThe Indiana Myeloma RegistryWho this might be right forPlasma Cell Dyscrasias Indiana University 2,500
Not applicableEnrolling By InvitationNCT04210791What this trial is testingAutologous Stem Cell Transplantation for Patients With AL AmyloidosisWho this might be right forAL AmyloidosisPlasma Cell Dyscrasia Nanjing University School of Medicine 500
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999
Large-scale testing (Phase 3)Active Not RecruitingNCT04512235What this trial is testingEvaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)Who this might be right forAL Amyloidosis Alexion Pharmaceuticals, Inc. 284
Large-scale testing (Phase 3)Active Not RecruitingNCT04504825What this trial is testingEvaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)Who this might be right forAL Amyloidosis Alexion Pharmaceuticals, Inc. 125
Testing effectiveness (Phase 2)Ended earlyNCT00942422What this trial is testingGreen Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition Barbara Ann Karmanos Cancer Institute 8
Not applicableLooking for participantsNCT06760052What this trial is testingLongitudinal Data Registry of Plasma Cell DyscrasiaWho this might be right forMultiple Myeloma and Other Plasma Cell Neoplasms Shanghai Zhongshan Hospital 2,000
Early research (Phase 1)Looking for participantsNCT06313502What this trial is testingHigh Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell DisordersWho this might be right forPlasma Cell Disorder University of Arkansas 18
Testing effectiveness (Phase 2)Study completedNCT00048412What this trial is testingStem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1HWho this might be right forMyelodysplastic DisordersLeukemiaMultiple Myeloma+2 more Baylor College of Medicine 40
Not applicableLooking for participantsNCT06870760What this trial is testingPre-malignant States to Hematologic Malignancies in FirefightersWho this might be right forClonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more Wake Forest University Health Sciences 300
Not applicableStudy completedNCT02274519What this trial is testingNovel Support Options in Autologous Stem Cell Transplant for Multiple MyelomaWho this might be right forMultiple MyelomaPlasma Cell Disorder Mayo Clinic 29
Large-scale testing (Phase 3)WithdrawnNCT02155634What this trial is testingContinuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in MyelomaWho this might be right forMultiple MyelomaNeoplasmsPlasma Cells+4 more Celgene